Tag Archives: CBI
By admin | Published: September 19, 2011
Pharmaceutical Executive recently spoke with David Vance, Senior Director of the Compliance Counsel at Noven Pharmaceuticals, about the birth of Expanded Access Programs and the role patient advocacy groups can play in shaping those programs.
By admin | Published: April 28, 2010
Image via Wikipedia The Center for Business Intelligence, on Monday, revealed winners of its annual Strategic Patient Adherence Awards as part of its two-day conference about patient compliance with their drug regiments. This year’s award winners are: Best Integrated Program—Shire Pharmaceuticals: FOSRENOL ON TRACK Direct To Patient Support Program Best Disease State Program—BMS/Sanofi-Aventis Canada & […]
By admin | Published: October 23, 2008
I’ve always been interested in pre-approval access because it is at the cutting-edge of bringing science and patients together – and it really is about helping those in need. But research presented today in Baltimore, at CBI‘s conference on Pre-Approval Access (sponsored by IDIS), shows that there is a financial return for providing these programs […]